Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease - Trial NCT06362863
Access comprehensive clinical trial information for NCT06362863 through Pure Global AI's free database. This phase not specified trial is sponsored by Ping An and is currently Not yet recruiting. The study focuses on Crohn's Disease. Target enrollment is 52 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ping An
Renmin Hospital of Wuhan University
Timeline & Enrollment
N/A
Jun 01, 2024
Dec 01, 2025
Primary Outcome
Crohn's disease activity index, CDAI
Summary
By conducting a randomized controlled study of the role of enteral nutrition biscuits in the
 induction of remission in moderate-to-severe Crohn's disease, we will evaluate to investigate
 the role of enteral nutrition biscuits in the induction and remission phases of
 moderate-to-severe Crohn's disease; to assess patient adherence to enteral nutrition biscuits
 and the timing of their application; to assess the role of enteral nutrition biscuits in
 biologically refractory patients; and to assess the role of enteral nutrition biscuits in the
 remission of perianal, small bowel, and colonic lesions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06362863
Non-Device Trial